# The Effects of HIV Protease Inhibitors in Severe Sepsis

> **NCT00346580** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 60 (—)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** Nelfinavir

## Key facts

- **NCT ID:** NCT00346580
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2005-09
- **Final completion:** 2005-09
- **Target enrollment:** 60 (—)
- **Last updated:** 2011-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00346580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00346580, "The Effects of HIV Protease Inhibitors in Severe Sepsis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00346580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*